🇩🇰 Denmark · Medical devices
Coloplast100IntegrityKVKristian VillumsenCEO, 2018–2025, ColoplastPromisedhow much profit it keeps from each krone of sales>30% margin; 7–9% growth30 September 2020↗
🇩🇰 Denmark · Medical devicesColoplast95IntegrityKVKristian VillumsenCEO, 2018–2025, ColoplastPartly kepthow much profit it keeps from each krone of sales>30% margin; 7–9% growth28% margin; 7% growth4 November 2025↗Near miss · −5 points
🇩🇰 Denmark · Medical devicesColoplast95IntegrityKVKristian VillumsenCEO, 2018–2025, Coloplast
Did Coloplast keep its promise to earn a margin above 30% by the end of Strive25? (plain)
The new promiseGrowth came in at the bottom of the range; the margin fell short.
Max Noble Odds: 50% chance he keeps it. They move with every call. Against the odds you win more, and lose more.
The small print, in plain words
- He promised
- Sales would grow 7–9% a year and the margin would be above 30%.
- He got
- 7% growth and a 28% margin in the final year.
- Why, says the company
- Product recalls, inflation and acquisitions weighed on profits.
- How bad
- Minor. Growth reached only the bottom of the range and the margin goal was missed. Score 100 → 95.
Read the promise ↗︎Coloplast full-year 2019/20 press release, 3 Nov 2020Read the result ↗︎Coloplast full-year 2024/25 results announcement, 4 Nov 2025Read the result ↗︎Coloplast 2024/25 'kort fortalt' (chair/CEO letter)